Alexion Pharmaceuticals, Inc.
Clinical trials sponsored by Alexion Pharmaceuticals, Inc., explained in plain language.
-
Can new treatment help patients ditch harmful steroids?
Disease control Not yet recruitingThis study aims to see if adults with generalized myasthenia gravis who are already receiving ravulizumab treatment can safely reduce or stop their steroid medications. Researchers will follow 75 participants as they follow a planned steroid reduction schedule while monitoring th…
Phase: PHASE4 • Sponsor: Alexion Pharmaceuticals, Inc. • Aim: Disease control
Last updated Mar 27, 2026 12:40 UTC
-
First human test for new drug begins
Knowledge-focused Not yet recruitingThis is an early safety study for a new drug called ALXN2230. It will test single injections in 48 healthy adult volunteers to see how safe it is and how the body handles it. The main goal is to check for side effects and measure the drug's levels in the blood over time.
Phase: PHASE1 • Sponsor: Alexion Pharmaceuticals, Inc. • Aim: Knowledge-focused
Last updated Mar 30, 2026 14:28 UTC